Retatrutide

30 mg

Independent testing records and certificate history for every documented Retatrutide 30 mg batch released by Pep Select.

Current Batch: ND_R30_060326
Latest Test: June 25, 2026

Current documented release

Latest report

Latest Report · Batch

ND_R30_060326Current Batch

This batch met every documented specification included in the independent laboratory panel. The original laboratory documentation is provided without alteration for review.

Test Date: June 25, 2026
Laboratory: ILS Labs
Report Type: Full-QC

Full-QC testing passed.7 of 7 laboratory categories reported. Independent documentation on file.

Independently tested
Documentation available
Identity confirmed

Purity✓ Pass: 97.62%
Average Net Content: 30.45 mg
Labeled Content: 30 mg
Vials Tested: 3

Laboratory Categories Reported

IdentityLC-MS · Confirmed
PurityHPLC · 97.62%
Net Content30.45 mg avg
Heavy MetalsArsenic, cadmium, chromium, mercury, and lead were not detected.
SterilityNo Growth
Endotoxins<0.05 EU/mL
Fentanyl ScreenNot detected

Active batch vetting

Incoming Reports

No new batches currently under vetting.

There are no active vendor or laboratory verification records for this compound at this time.

Complete transparent record

Previous reports

Previous batch records remain available so each documented release can be reviewed independently. Retention of historical records is part of Pep Select’s testing policy.

No previous completed reports are available.